Aileron Therapeutics, Inc. (ALRN)
ALRN has a market cap or net worth of $42.03 million. The enterprise value is -$10.04 million.
ALRN has 90.57 million shares outstanding. The number of shares has increased by 130.28% in one year.
|Shares Change (YoY)||+130.28%|
|Shares Change (QoQ)||+0.10%|
|Owned by Insiders (%)||10.38%|
|Owned by Institutions (%)||36.38%|
|EV / Earnings||n/a|
|EV / Sales||n/a|
|EV / EBITDA||n/a|
|EV / EBIT||n/a|
|EV / FCF||n/a|
The company has a current ratio of 11.94, with a Debt / Equity ratio of 0.00.
|Debt / Equity||0.00|
|Debt / EBITDA||n/a|
|Debt / FCF||n/a|
Return on equity (ROE) is -54.20%, which is considered low. The company has a ROIC of -71.40%.
|Return on Equity (ROE)||-54.20%|
|Return on Assets (ROA)||-49.60%|
|Return on Capital (ROIC)||-71.40%|
|Revenue Per Employee||n/a|
|Profits Per Employee||-$3.05M|
|Effective Tax Rate||n/a|
Stock Price Statistics
The stock price has decreased by -75.14% in the last 52 weeks. The beta is 2.55, so ALRN's price volatility has been higher than the market average.
|52-Week Price Change||-75.14%|
|50-Day Moving Average||0.53|
|200-Day Moving Average||0.87|
|Average Volume (30 Days)||467,893|
Short Selling Information
|Short % of Shares Out||0.21%|
|Short % of Float||0.32%|
|Short Ratio (days to cover)||0.36|
|Earnings Per Share (EPS)||-$0.32|
The company has $52.26 million in cash and $192,000 in debt, giving a net cash position of $52.07 million or $0.57 per share.
|Cash & Cash Equivalents||52.26M|
|Net Cash Per Share||$0.57|
|Book Value Per Share||0.55|
In the last 12 months, operating cash flow was -$22.19 million and capital expenditures $51,000, giving a free cash flow of -$22.14 million.
|Operating Cash Flow||-22.19M|
|Free Cash Flow||-22.14M|
|FCF Per Share||n/a|
Dividends & Yields
ALRN does not appear to pay any dividends at this time.
|Dividend Per Share||n/a|
|Dividend Growth (YoY)||n/a|
This stock does not have any record of stock splits.
|Last Split Date||n/a|